deCODE genetics Report issue

For profit Phase 3 Phase 4
Founded: Reykjavik Iceland (1996)
Status: Acquired by Amgen (2012)

Organization Overview

First Clinical Trial
2006
NCT00353067
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

deCODE genetics | deCODE Genetics | deCODE genetics, Iceland | Iceland Genomics Corporation